Pulse Biosciences, Inc. (PLSE)
$46.32-4.57%Close
SELLCRISIS · day 1
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $3.2B
- Beta
- 1.57
- P/E (TTM)
- -39.59
- Short % float
- 25.94%
- Days to cover
- 5.6
- SI change
- +5.5%
- 1W
- -5.64%
- 1M
- -16.09%
- vs SPY 1W
- -5.50%
- vs SPY 1M
- -18.59%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on PLSE?
- LOPJLB’s latest quantitative signal on Pulse Biosciences, Inc. (PLSE) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is PLSE in?
- Pulse Biosciences, Inc. (PLSE) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Pulse Biosciences, Inc. (PLSE) do?
- Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric medicine. Their primary offering is the CellFX System, a sophisticated, console-based platform that is precisely controlled via software. This system utilizes its proprietary Nano-Pulse Stimulation technology to deliver extremely brief, nanosecond-duration electrical pulses. This advanced method is designed to selectively…